Lamivudine 150mg Tablet (Lamipure) (Lamivudine)
Prescription RequiredManufactured By
Aprazer
Pack Of
30
Salt Composition
Lamivudine
Storage
Keep in cold place
Overview
Lamivudine 150mg Tablet (Lamipure) is an antiviral medicine with Lamivudine as an active ingredient. It is prescribed to treat chronic hepatitis B virus (HBV) infection & HIV infection. It prevents the multiplication of viruses in human cells. It works by stopping the virus from producing new viruses and removing your infection. It should be taken in dose and duration as advice by the doctor. Don't take more than the recommended dose.
Quick Product Facts
| Field | Publication wording |
|---|---|
| Brand | lamipure |
| Generic / Active Ingredient | Lamivudine |
| Strength | 150 |
| Dosage Form | Tablet |
| Manufacturer / Marketer | Aprazer |
| Pack Size | 30 |
| Prescription Required | Yes |
| Therapeutic Categories | HIV Medicines |
| Uses | HIV |
Uses and Indications
HIV and Hepatitis B Virus
Side Effects of Lamivudine 150mg Tablet (Lamipure)
It is a strong antiviral medicine that may show certain adverse while manageable impact on the body during the treatment. As these effects resolve on their own without any special medical attention. However, if you ever experience serious or unusual side effects contact your healthcare professional immediately.
Some common side effects include:
● Nausea
● Diarrhea
● Headache
● Vomiting
● Fatigue
● Stomach pain
● Rash
Lamivudine 150mg Tablet (Lamipure) Dosage and How To Take It
Doctor determines the dosage and duration of Lamivudine 150mg Tablet as per the type of disease and overall health condition of the patients. Swallow it as a whole with water. Do not chew, crush or break it. This tablet may be taken with or without food. In case of an overdose of this tablet, contact your doctor or any healthcare provider and seek medical attention immediately.
Safety Advice for Lamivudine 150mg Tablet (Lamipure)
- ● Alcohol: Avoid the consumption of alcohol while taking Lamivudine 150mg, as alcohol can decrease the effectiveness of the medicine as well as worsen the symptoms
- ● Pregnancy: Do not take Lamivudine 150mg without consulting the doctor in case of pregnancy, as it is an unsafe to take it during this period.
- ● Breastfeeding: Lamivudine 150mg is safe to use while breastfeeding, if prescribed by the doctor. No dosage adjustment is necessary for this tablet as limited data is available that shows significant risk.
- ● Driving: Lamivudine 150mg is safe to use while driving as it does not usually affect your ability to drive.
- ● Kidney: Share your medical history with the doctor before starting the treatment with Lamivudine 150mg. Do not take it without consulting a doctor if you have any liver related issue.
- ● Liver: Lamivudine 150mg is safe for use in kidney disease if prescribed by the doctor. No dosage adjustment is necessary for this Tablet.
FAQs About Lamivudine 150mg Tablet (Lamipure)
What are the uses of Lamivudine 150mg Tablet?
It is an antiviral medicine that is used to treat chronic hepatitis B virus (HBV) infection & HIV infection.
What are the common side effects of taking Lamivudine 150mg Tablet?
There are some common yet manageable side effects of taking Lamivudine 150mg Tablet that include stomach pain, nausea, abdominal pain, constipation, decreased appetite, dizziness, etc.
How does Lamivudine 150mg Tablet work?
Lamivudine 150mg Tablet is a strong antiviral medicines that work by reducing the viral load of in body and eliminate the virus from body over time.
Is it safe to drive after taking Lamivudine 150mg Tablet?
It is better to avoid driving after taking this medicine as dizziness or lack of focus can be the common symptoms of this tablet.
Is it safe to take Lamivudine 150mg Tablet if a patient has kidney or liver related condition?
Avoid the consumption of Lamivudine 150mg Tablet if you have any kidney related issue without consulting the doctor, however it is safe to use in liver related issues after doctor prescription.
References
● Chien, R. N., Yeh, C. T., Tsai, S. L., Chu, C. M., & Liaw, Y. F. (2003). Determinants for sustained HBeAg response to lamivudine therapy. Hepatology, 38(5), 1267-1273.
● Ryu, S. H., Chung, Y. H., Choi, M. H., Kim, J. A., Shin, J. W., Jang, M. K., ... & Suh, D. J. (2003). Long-term additional lamivudine therapy enhances durability of lamivudine-induced HBeAg loss: a prospective study. Journal of hepatology, 39(4), 614-619.
● Perry, C. M., & Faulds, D. (1997). Lamivudine: a review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in the management of HIV infection. Drugs, 53(4), 657-680.
● Liaw, Y. F., Leung, N. W., Chang, T. T., Guan, R., Tai, D. I., Ng, K. Y., ... & Asia Hepatitis Lamivudine Study Group. (2000). Effects of extended lamivudine therapy in Asian patients with chronic hepatitis B. Gastroenterology, 119(1), 172-180.
● Dienstag, J. L., Goldin, R. D., Heathcote, E. J., Hann, H. W. L., Woessner, M., Stephenson, S. L., ... & Schiff, E. R. (2003). Histological outcome during long-term lamivudine therapy. Gastroenterology, 124(1), 105-117.
Marketer Details
Aprazer
Author Details
Written By:
Nonish Sharma
I am a medical content writer with a strong academic background in life sciences, holding an M.Sc. in Biotechnology... Read More
Reviewed By:
Vaibhav Shakya
Dr. Vaibhav Shakya, MD, is a Medical reviewer and medicine expert at Globans Pharma, with more than 9 years of experienc... Read More
Want to know More
Check our Editor Policy
Disclaimer
Globanspharma main goal is to ensure that its consumers get correct, authentic, and reliable information that has been examined by medical professionals. This website's content has only been created for informational purposes. However, this is not meant to replace the medical advice and treatment given by a qualified physician. The information presented herein may not cover everything about particular lab tests, medicines, and health conditions, all possible side effects, and warnings. Please discuss all your queries related to any medication and illness with your doctor. We intend to support and maintain the doctor-patient relationship, not to substitute it or take its place.
